Concepedia

Maria Teresa Bilotta

MT

Statistics

Publications

6

Citations

183

H-Index

6

Active since

2016

Affiliations

Istituto Pasteur(Current)

Istituto Neurologico Mediterraneo

Sapienza University of Rome

National Institutes of Health

National Cancer Institute

Maria Teresa Bilotta is an author at Istituto Pasteur specializing in tumor biology, cancer therapeutics, and cancer research.

ORCID

Top concepts

Publications per year

2016–2023

6

Publications

6

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay

Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda et al. · Journal of Hematology & Oncology · 2016 · 90 citations · Full text

Activation of liver X receptor up‐regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms

Maria Teresa Bilotta, Maria Pia Abruzzese, Rosa Molfetta et al. · The FASEB Journal · 2019 · 26 citations

Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

Nicola Tumino, Maria Teresa Bilotta, Carmela Pinnetti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 24 citations · Full text

The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors

Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda et al. · Cell Death and Disease · 2019 · 17 citations · Full text

Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity

Eric Ho, Rong Qiu, Ellis Miller et al. · Biomedicine & Pharmacotherapy · 2022 · 13 citations · Full text

, , +18

1–5 of 6